Healthcare

Iranin knowledge-based company indigenizes production of cancer treatment medicine

Iran has started production of a drug internationally used for treatment of cancer at home which will save the country five million dollars annually.

Iran’s Vice-President for Science, Technology and Knowledge-Based Economy Rouhollah Dehghani Firouzabadi unveiled the domestically-made production line of cyclophosphamide at Nanoalvand Company

on Friday in Karaj, near Tehran.

Cancer patients in Iran have been severely affected by the relentless US-led Western sanctions over the country’s nuclear program, which Tehran asserts has been peaceful.

The Iranian vice president said the country needs about 400 thousand doses of the drug every year that will be sufficiently met with the new production line.

Cyclophosphamide is used in the treatment of a wide range of cancers, including blood, ovarian, breast, and eye cancers.

IFP Editorial Staff

The IFP Editorial Staff is composed of dozens of skilled journalists, news-writers, and analysts whose works are edited and published by experienced editors specialized in Iran News. The editor of each IFP Service is responsible for the report published by the Iran Front Page (IFP) news website, and can be contacted through the ways mentioned in the "IFP Editorial Staff" section.